Article

Brain connectivity linked with pain intensity in fibromyalgia

Instrinsic connectivity is disrupted within multiple brain networks in patients with fibromyalgia syndrome (FMS). Elevated intrinsic brain connectivity is linked with spontaneous pain intensity in these patients.

Instrinsic connectivity is disrupted within multiple brain networks in patients with fibromyalgia syndrome (FMS). Elevated intrinsic brain connectivity is linked with spontaneous pain intensity in these patients.

Napadow and coworkers tested the hypothesis that default mode network (DMN) and executive attention network (EAN) connectivity is altered in patients with FMS and affects their pain level. DMNs are deactivated during acute pain, but this response is blunted in persons with chronic pain; the EAN processes working memory and attention, skills compromised in FMS. As a negative control, they used a parameter unaffected by FMS, medial visual net-work connectivity. Brain activity was measured with resting-state functional MRI.

Patients with FMS had more connectivity within the DMN and right EAN than others. They also had more connectivity between the DMN and insular cortex, a region that processes evoked pain. Patients with the worst pain showed the greatest connectivity between the insula and both the DMN and right EAN. These measures document that pain is related to brain activity within interconnected networks in FMS.

The authors noted that their findings have implications for a better understanding of the underlying brain mechanisms of endogenous clinical pain in FMS, potentially pointing toward markers of disease progression.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.